Peden, Keith

Development of mRNA Vaccines: Scientific and Regulatory Issues

Knezevic, I., Liu, M. A., Peden, K., Zhou, T., & Kang, H.-N. (2021) · Vaccines

SARS-CoV-2 and COVID-19 ResearchRNA Interference and Gene Delivery

Cited by 114

Issues associated with residual cell-substrate DNA in viral vaccines

Sheng-Fowler, L., Lewis, A. M., & Peden, K. (2009) · Biologicals

Viral Infectious Diseases and Gene Expression in InsectsVirus-based gene therapy research

Cited by 53

Oncogenicity of DNA in vivo: Tumor induction with expression plasmids for activated H-ras and c-myc

Sheng, L., Cai, F., Zhu, Y., Pal, A., Athanasiou, M., Orrison, B., Blair, D. G., Hughes, S. H., Coffin, J. M., Lewis, A. M., et al. (2008) · Biologicals

Carcinogens and Genotoxicity AssessmentImmunotherapy and Immune Responses

Cited by 35

Tumors Induced in Mice by Direct Inoculation of Plasmid DNA Expressing Both Activated H-ras and c-myc

Sheng-Fowler, L., Cai, F., Fu, H., Zhu, Y., Orrison, B., Foseh, G., Blair, D. G., Hughes, S. H., Coffin, J. M., Lewis Jr, A. M., et al. (2010) · International Journal of Biological Sciences

Carcinogens and Genotoxicity AssessmentImmunotherapy and Immune Responses

Cited by 11

A Mouse Strain Defective in Both T Cells and NK Cells Has Enhanced Sensitivity to Tumor Induction by Plasmid DNA Expressing Both Activated H-Ras and c-Myc

Sheng-Fowler, L., Tu, W., Fu, H., Murata, H., Lanning, L., Foseh, G., Macauley, J., Blair, D., Hughes, S. H., Coffin, J. M., et al. (2014) · PLoS ONE

Carcinogens and Genotoxicity AssessmentImmunotherapy and Immune Responses

Cited by 7